Pharmaceutical programs
Small Molecule & Oral-Solid Programs
Regulatory strategy, CMC evidence, Module 3, lifecycle controls, specifications, and submission readiness.
- Module 3
- Lifecycle
- Specifications
Who XGene helps
Find the XGene pathway that fits your work.
Start with your product, program, site, or pressure point. Then connect directly to the most relevant XGene service pathway.
Operating contexts
Find the context that looks most like your work.
These are not rigid industry silos. They are practical entry points for finding the technical and regulatory capabilities that fit the work in front of your team.
Pharmaceutical programs
Small Molecule & Oral-Solid Programs
Regulatory strategy, CMC evidence, Module 3, lifecycle controls, specifications, and submission readiness.
Explore the pathway → Advanced therapiesBiologics & Advanced Modalities
CMC strategy for biologics, cell and gene therapy, LNP/mRNA, and other programs where modality-specific controls shape the dossier.
Explore the pathway → Manufacturing environmentsSterile, Injectable & High-Control Operations
Inspection readiness, contamination-control thinking, quality-system execution, and evidence needed to demonstrate sustained control.
Explore the pathway → External manufacturingCDMO / CMO & Technology Transfer
Transfer, qualification, oversight, evidence handoffs, manufacturing-chain decisions, and readiness before a receiving site or partner becomes the next risk point.
Explore the pathway → Global programsInternational Regulatory & Submission Programs
Multi-region CMC strategy, regulatory evidence, submission planning, and harmonization when one technical package must support different review systems.
Explore the pathway → High-stakes remediationQuality, Inspection & Enforcement Response
Programs where a finding, inspection, recurring deviation, data-integrity concern, or remediation commitment has become a management-system decision.
Explore the pathway → Digital qualityData Integrity & Digital Quality Programs
Programs where data completeness, audit trails, electronic records, and digital quality controls must remain defensible across laboratory, manufacturing, quality, and regulatory workflows.
Explore the pathway → CMC modernizationAI-Enabled CMC & Regulatory Modernization
Programs modernizing structured CMC content, regulatory data, and AI-assisted workflows while preserving traceability, accountable scientific review, and regulatory judgment.
Explore the pathway →A better way to self-select
Start with the decision pressure—not an industry label.
The same organization can need different expertise at different moments. XGene's service architecture is designed around the decision that must be defended, implemented, or verified.
01
Submission or lifecycle decisionStrategy · dossier · evidence · specifications · change
02
Quality-system or data decisionRoot cause · CAPA · governance · ALCOA+ · controls
03
Inspection or enforcement decisionReadiness · response · remediation · effectiveness
04
Transfer or external-partner decisionQualification · oversight · comparability · handoff
Not sure which pathway fits?